Keynote Lecture

Hiroaki Ikeda

Nagasaki University School of Medicine

Development of cancer immunotherapy that overcomes tumor heterogeneity

Special Symposium
Industry-Academia-Government collaboration and more

Yoshihiro Miyahara

Mie University Graduate School of Medicine

Koji Tamada

The Research Institute for Cell Design Medical Science, Yamaguchi University
Yamaguchi University Graduate School of Medicine, Department of Immunology

Endeavor for the research and development of next-generation CAR-T cell therapy

Jun Matsumoto

Pharmaceuticals and Medical Devices Agency

Takashi Futami

AN Venture Partners

Symposium

Symposium　1
「Treatment of solid tumors with gene-modified immune cells」

Carl June

University of Pennsylvania Perelman School of Medicine, Abramson Cancer Center

Challenges and opportunities for CAR T cells in solid tumors

Koichi Hirabayashi

Shinshu University School of Medicine

CAR-T therapy targeting epidermal growth factor receptor (EGFR)

Keishi Adachi

Yamaguchi University Faculty of Medicine and Health Sciences

The development of a novel chimeric antigen receptor (CAR) T-cell therapy platform targeting solid tumors

Sikun Meng

Graduate School of Medicine Faculty of Medicine, Osaka University

mRNA vaccine encoding CAR targeting FAP (Tentative)

Symposium　2
「Cutting-edge technologies in spatial analysis and single cell omics analysis」

Athena Golfinos-Owens

Johns Hopkins University School of Medicine

Integrated single-cell and spatial analysis of immune cell interactions in response to immune checkpoint blockade (Tentative)

Ayako Suzuki

Graduate School of Frontier Sciences, The University of Tokyo

Spatial omics analyses for revealing molecular mechanisms of lung cancer progression

Kouji Okamoto

Teikyo University Advanced Comprehensive Research Organization

Spatial Omics Analyses of Ovarian Cancer

Yoshiaki Abe

Institute of Medicine, University of Tsukuba

Microenvironment in lymphoma (Tentative)

Symposium　3
「Antibody-based cancer therapy: Immune checkpoint inhibitors, antibody-drug conjugates and bispecific antibodies.」

Juan C. Osorio

Memorial Sloan Kettering Cancer Center

Treatment of Cancer with anti-CD47/ CD40 antibodies (Tentative)

Ryutaro Asano

Tokyo University of Agriculture and Technology

Design, analysis, and prodrugation of multispecific antibodies for cancer therapeutics

Akiko Zembutsu

Development of ADC to cancers (Tentative)

Shigehisa Kitano

Advanced Medical Development Center, CANCER INSTITUTE HOSPITAL OF JFCR

Development Status of Immune Checkpoint Inhibitors

Symposium　4
「The potential of immunotherapy for biliary tumors」

Shogo Kumagai

Division of Cancer immunology, Research Institute, National Cancer Center

Immune Microenvironment of Biliary Tract Cancers

Reona Sakemura

Mayo Clinic

Engineered T-Cell Therapy for Biliary Tract Cancers

Takashi Mizuno

Nagoya University Graduate School of Medicine

Current status of Immune checkpoint inhibitor therapy for biliary tract cance

Educational Lectures

Educational Lecture　1

Mitsuru Miyata

Miyata Institute of Technologies

Educational Lecture　2

Kouhei Tsumoto

Faculty Of Engineering, The University of Tokyo

Educational Lecture　3

Naoki Hosen

Department of Hematology and Oncology, Osaka University School of Medicine

Current status and perspectives of cell therapy and immunotherapy for hematological cancers

Educational Lecture　4

Shohei Koyama

Department of Immunogenomic Medicine, Research Institute, National Cancer Center

Tumor Immune Microenvironment: From Fundamentals to Cutting-Edge Insights

Educational Lecture　5

Shumpei Ishikawa

Graduate School of Medicine, The University of Tokyo

Extraction of Spatial Information of Tumor Tissue

Educational Lecture　6

Kenji Chamoto

Center for Cancer Immunology and Cancer Immunotherapy

Symposium organized by the Academic Committee

Chair

Shinichirou Fujii

Riken Center for Integrative Medical Sciences(IMS)

Kazuhiro Kakimi

Department of Immunotherapeutics, The Univercity of Tokyo Hospital

Presenters

Hidetaka Akita

Graduate School of Pharmaceutical Sciences & Faculty of Pharmaceutical Sciences, Tohoku University

Immune activation and cancer therapy based on the Lipid nanoparticle (LNP)

Akiko Ogawa

Department of Modomics Medicine & Biology, Tohoku University

Decoding Cancer Immunopathology through RNA Modomics

Sayuri Yamazaki

Department of Immunology, Nagoya City University Graduate School of Medical Sciences

Immune regulation by dendritic cell - regulatory T cell crosstalk and tumor microenvironment

Rui Yamaguchi

Division of Cancer Systems Biology, Aichi Cancer Center Research Institute

Development of a machine learning model for predicting protein binding affinities toward immune receptor protein design

All presentation slides will be prepared in English.
Invited foreign speakers will give their presentation in English while others will mainly do so in Japanese.
However, we will provide real-time Zoom translated captions into English from other languages.